Proto Labs (PRLB) Cash & Equivalents (2011 - 2026)

Proto Labs has reported Cash & Equivalents for 16 years, with the latest figure at $127.9 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $127.9 million, up 41.53% year-over-year; the trailing twelve-month figure through Jun 2026 was $127.9 million (up 41.53% YoY), and the FY2025 annual result was $110.8 million, up 24.42% from the prior year.
• Cash & Equivalents grew to $127.9 million in Q2 2026, from $124.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $127.9 million in Q2 2026 and troughed at $54.7 million in Q2 2022.
• A 5-year average of $85.0 million and a median of $85.8 million in 2023 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2022, when Cash & Equivalents dropped 14.21%; it then soared 49.92% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $56.6 million in 2022, then soared by 48.15% to $83.8 million in 2023, then rose by 6.3% to $89.1 million in 2024, then climbed by 24.42% to $110.8 million in 2025, then increased by 15.42% to $127.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $127.9 million in Q2 2026, $124.0 million in Q1 2026, and $110.8 million in Q4 2025.